Study on the Effect of dexmedetomidine on neuroelectrophysiological monitoring in spinal surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800016716

Enrollment

Unknown

Registered

2018-06-19

Start date

2018-07-01

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrophysiological monitoring in spinal surgery

Interventions

Dexmedetomidin control group A:placebo

Dexmedetomidin experimental group B:Dexmedetomidine load dose 0.5µg/kg

Dexmedetomidin experimental group C:Dexmedetomidine load dose 1.0µg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. Good health at ordinary times and ASA classification I to III; 3. Patients receiving spinal surgery; 4. Informed consent, volunteer subjects.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to anaesthetic or have serious organic diseases; 2. Hypersensitivity to dexmedetomidine; 3. Pregnant, lactating women, late cardiac arrest patients; 4. The function of the extremities was lost.

Design outcomes

Primary

Measure	Time frame
Somatosensory evoked potential;Motor evoked potential;	—

Countries

China

Contacts

Public ContactWanchao Yang

Second Affiliated Hospital of Harbin Medical University

dachao_1980@126.com+86 13796636010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026